SB 421 — Restrictions on copayments.
Last action — Senator Ford J.D. added as coauthor
-
✓Introduced
-
2In Committee
-
3Passed Senate
-
4Passed House
-
5To Executive
-
6Enacted
This bill died with 2020 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
Summary
Requires a state employee health plan, a policy of accident and sickness insurance, and a health maintenance organization contract to provide coverage without cost sharing for auto-injectable epinephrine that is prescribed to individuals less than 18 years of age. Requires an insurer to cap the total amount an insured is required to pay for a 30 day supply of a prescription insulin drug at an amount not to exceed $50, regardless of the amount or type of insulin prescribed to the insured.
Bill Text
We don't have the full text on file for this bill yet.
Read SB 421 on the official Indiana source →Action History
-
Senator Ford J.D. added as coauthor
-
Senator Stoops added as coauthor
-
First reading: referred to Committee on Insurance and Financial Institutions
-
Authored by Senator Melton
Sponsors
- J.D. Ford · Cosponsor
- Mark Stoops · Cosponsor
- Eddie Melton · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 2 co-sponsors · 147 not signed on
Sponsors (1)
- Eddie Melton
Co-sponsors (2)
- J.D. Ford Democrat
- Mark Stoops
Not signed on (147)
147 members have not signed on to this bill.
Show all 147 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does SB 421 do?
- Requires a state employee health plan, a policy of accident and sickness insurance, and a health maintenance organization contract to provide coverage without cost sharing for auto-injectable epinephrine that is prescribed to individuals less than 18 years of age. Requires an insurer to cap the total amount an insured is required to pay for a 30 day supply of a prescription insulin drug at an amount not to exceed $50, regardless of the amount or type of insulin prescribed to the insured.
- Who sponsors SB 421?
- SB 421 is sponsored by J.D. Ford (Democrat), Mark Stoops, and Eddie Melton.
- What is the current status of SB 421?
- This bill died with 2020 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track SB 421?
- Track SB 421 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on SB 421
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of SB 421
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →